Podcasts Technology Austrian Artificial Intelligence Podcast 17. Noah Weber - Celeris Therapeutics: MLOps and Degrader Molecule Design

17. Noah Weber - Celeris Therapeutics: MLOps and Degrader Molecule Design

Published: Nov. 27, 2021, 2:17 p.m.

b"

# Intro
\\nNoah Weber is the Chief Technology offer at Celeris Therapeutics. Celeris is discovering candidates for targeted protein degradation in silico using Artificial Intelligence, to accelerate drug discovery and find cures for diseases like Alzheimer's.

\\n

In the first part of the show, he shares his experience on the importance of good MLOps practices and the importance of cloud solutions for the development of AI products at scale. 

\\n

In the second part, we talk about the core technology that Celeris has developed to solve the problem of finding candidates for targeted protein degradation. Noah explains the problem they are solving from a computational perspective and we discuss how they use Bayesian optimization to evaluate and rank candidates in silico, reducing the costs and time for drug discovery.

\\n

# References
\\nNoah Weber - https://www.linkedin.com/in/noahweber123
\\nCeleris Therapeutics - https://celeristx.com
\\nAI-driven degrader design - https://www.youtube.com/watch?v=p2OjZ5afyLw
\\nACIT Podcast with Noah Weber - https://open.spotify.com/episode/61eXYwKpVuj1w8l0fiyEh5?si=n0vKpaXLTNKz0nwIpJaGMw

"